March 7, 2013 — Mercator MedSystems Inc. announced it has received CE mark approval to market its Cricket and Bullfrog ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 07, 2013
February 21, 2013 — Today, Time Magazine releases the dramatic findings of a months-long investigation by contributor ...
February 21, 2013January 25, 2013 — The American College of Cardiology (ACC) has released the late-breaking clinical trials that will be ...
January 25, 2013
December 28, 2012 — The past year in cardiology has continued to see progress and innovation in medicine. As the year ...
December 28, 2012December 28, 2012 — Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to ...
December 28, 2012December 20, 2012 — The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public ...
December 20, 2012
December 10, 2012 — The U.S. Food and Drug Administration (FDA) is notifying healthcare professionals, caregivers and ...
December 10, 2012
One-year results from the ADAPT-DES Trial were presented during TCT 2012. It examined patient hyporesponsiveness to ...
December 07, 2012December 6, 2012 — Daiichi Sankyo Inc. and Eli Lilly and Co. announced results of two retrospective, observational ...
December 06, 2012
November 30, 2012 — Results of a study investigating the effects of smoking on the antiplatelet medications clopidogrel ...
November 30, 2012November 30, 2012 — A large observational study found the increased risk associated with dual antiplatelet therapy cessa ...
November 30, 2012Use of Rosuvastatin Prior to Angioplasty Does Not Influence Troponin I Release Following Angioplasty
November 9, 2012 — A study found that the use of rosuvastatin prior to angioplasty did not influence the levels of ...
November 09, 2012November 9, 2012 — Bristol-Myers Squibb Co. and Pfizer Inc. announced that the reductions in stroke or systemic embolism ...
November 09, 2012
November 7, 2012 — Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved ...
November 07, 2012
November 2, 2012 — Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
November 02, 2012